Cargando…
Lumican mediates HTB94 chondrosarcoma cell growth via an IGF-IR/Erk1/2 axis
Chondrosarcoma is a malignant bone tumor characterized by the production of a modified cartilage-type extracellular matrix (ECM). In the present study, the expression levels of the small leucine-rich proteoglycans (SLRPs), decorin, biglycan and lumican, were examined in the HTB94 human chondrosarcom...
Autores principales: | Papoutsidakis, Antonis, Giatagana, Eirini Maria, Berdiaki, Aikaterini, Spyridaki, Ioanna, Spandidos, Demetrios A., Tsatsakis, Aristidis, Tzanakakis, George N., Nikitovic, Dragana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384848/ https://www.ncbi.nlm.nih.gov/pubmed/32705211 http://dx.doi.org/10.3892/ijo.2020.5094 |
Ejemplares similares
-
Lumican in Carcinogenesis—Revisited
por: Giatagana, Eirini-Maria, et al.
Publicado: (2021) -
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis
por: Tzanakakis, George N., et al.
Publicado: (2021) -
The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican
por: Berdiaki, Aikaterini, et al.
Publicado: (2023) -
Biglycan Regulates MG63 Osteosarcoma Cell Growth Through a LPR6/β-Catenin/IGFR-IR Signaling Axis
por: Aggelidakis, John, et al.
Publicado: (2018) -
Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors
por: Tzanakakis, George, et al.
Publicado: (2020)